Astex Therapeutics Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 183

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $151M

Astex Therapeutics General Information

Description

Operator of a biotechnology company focused on the discovery and development of drugs in oncology and other areas. The company uses its fragment-based drug discovery technology to identify and develop new medicines, primarily for the treatment of cancer and antiviral diseases, thereby helping in optimizing the pharmacokinetic properties and safety of their lead compounds.

Contact Information

Formerly Known As
Astex Technology
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 436 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0QA
  • England, United Kingdom
+44 01223
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 436 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0QA
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Astex Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 20-Jul-2011 $151M Completed Profitable
7. Later Stage VC 21-Dec-2010 Completed Profitable
6. Grant 02-Mar-2009 Completed Profitable
5. Later Stage VC Completed Profitable
4. Later Stage VC 05-Nov-2003 Completed Profitable
3. Early Stage VC 17-Dec-2001 Completed Product Development
2. Early Stage VC 14-May-2001 $32.5M $32.5M Completed Product Development
1. Early Stage VC 03-Dec-1999 Completed Product Development
To view Astex Therapeutics’s complete valuation and funding history, request access »

Astex Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C Preferred Ordinary
B Preferred Ordinary
To view Astex Therapeutics’s complete cap table history, request access »

Astex Therapeutics Patents

Astex Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4436571-A1 Small molecule inhibitors of kras mutated proteins Pending 24-Nov-2021
EP-4436571-A4 Small molecule inhibitors of kras mutated proteins Pending 24-Nov-2021
US-20260200925-A1 Small molecule inhibitors of kras mutated proteins Pending 24-Nov-2021
WO-2023097227-A1 Small molecule inhibitors of kras mutated proteins Inactive 24-Nov-2021
JP-2024543879-A Small molecule inhibitors of mutant kras proteins Pending 24-Nov-2021 A61K45/06
To view Astex Therapeutics’s complete patent history, request access »

Astex Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Astex Therapeutics Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
Advent International PE/Buyout Minority
Alta Partners Venture Capital Minority
Gimv PE/Buyout Minority
Novartis Venture Fund Corporate Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Astex Therapeutics FAQs

  • When was Astex Therapeutics founded?

    Astex Therapeutics was founded in 1999.

  • Where is Astex Therapeutics headquartered?

    Astex Therapeutics is headquartered in Cambridge, United Kingdom.

  • What is the size of Astex Therapeutics?

    Astex Therapeutics has 183 total employees.

  • What industry is Astex Therapeutics in?

    Astex Therapeutics’s primary industry is Drug Discovery.

  • Is Astex Therapeutics a private or public company?

    Astex Therapeutics is a Private company.

  • What is the current valuation of Astex Therapeutics?

    The current valuation of Astex Therapeutics is .

  • What is Astex Therapeutics’s current revenue?

    The current revenue for Astex Therapeutics is .

  • How much funding has Astex Therapeutics raised over time?

    Astex Therapeutics has raised $87.8M.

  • Who are Astex Therapeutics’s investors?

    Abingworth, Advent International, Alta Partners, Gimv, and Novartis Venture Fund are 5 of 8 investors who have invested in Astex Therapeutics.

  • When was Astex Therapeutics acquired?

    Astex Therapeutics was acquired on 20-Jul-2011.

  • Who acquired Astex Therapeutics?

    Astex Therapeutics was acquired by Astex Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process